At 10 mg kg−1, 5-FU did not significantly inhibit E0771 breast cancer growth and addition of 5-FU did not affected the growth rate of tumors treated with VEGF blockade plus imatinib (Supplementary Fig. 8a). This evidence concerns the gene VEGFA and breast carcinoma.